Elan D Louis1, Julián Benito-León, Félix Bermejo-Pareja. 1. Department of Neurology, GH Sergievsky Center, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA. EDL2@columbia.edu
Abstract
BACKGROUND: Recent interest in antihypertensive agents, especially calcium channel blockers, has been sparked by the notion that these medications may be neuroprotective. A modest literature, with mixed results, has examined whether these medications might lower the odds or risk of Parkinson's disease (PD) or dementia. There are no data for essential tremor (ET). OBJECTIVE: To examine the association between antihypertensive use (defined broadly and by individual subclasses) and ET, PD and dementia. For each disorder, we used cross-sectional data (association with prevalent disease) and prospective data (association with incident disease). METHODS: Prospective population-based study in Spain enrolling 5,278 participants at baseline. RESULTS: Use of antihypertensive medications (aside from beta-blockers) was similar in prevalent ET cases and controls. Baseline use of antihypertensive agents was not associated with reduced risk of incident ET. Antihypertensive medication use was not associated with prevalent or incident PD. Calcium channel blocker use was marginally reduced in prevalent dementia cases (OR(adjusted) = 0.63, p = 0.06) but was not associated with reduced risk of incident dementia (RR(adjusted) = 1.02, p = 0.95). CONCLUSIONS: We did not find evidence of a protective effect of antihypertensive medications in these three neurodegenerative disorders. Copyright 2009 S. Karger AG, Basel.
BACKGROUND: Recent interest in antihypertensive agents, especially calcium channel blockers, has been sparked by the notion that these medications may be neuroprotective. A modest literature, with mixed results, has examined whether these medications might lower the odds or risk of Parkinson's disease (PD) or dementia. There are no data for essential tremor (ET). OBJECTIVE: To examine the association between antihypertensive use (defined broadly and by individual subclasses) and ET, PD and dementia. For each disorder, we used cross-sectional data (association with prevalent disease) and prospective data (association with incident disease). METHODS: Prospective population-based study in Spain enrolling 5,278 participants at baseline. RESULTS: Use of antihypertensive medications (aside from beta-blockers) was similar in prevalent ET cases and controls. Baseline use of antihypertensive agents was not associated with reduced risk of incident ET. Antihypertensive medication use was not associated with prevalent or incident PD. Calcium channel blocker use was marginally reduced in prevalent dementia cases (OR(adjusted) = 0.63, p = 0.06) but was not associated with reduced risk of incident dementia (RR(adjusted) = 1.02, p = 0.95). CONCLUSIONS: We did not find evidence of a protective effect of antihypertensive medications in these three neurodegenerative disorders. Copyright 2009 S. Karger AG, Basel.
Authors: O Dogu; S Sevim; H Camdeviren; T Sasmaz; R Bugdayci; M Aral; H Kaleagasi; S Un; E D Louis Journal: Neurology Date: 2003-12-23 Impact factor: 9.910
Authors: T A Zesiewicz; R Elble; E D Louis; R A Hauser; K L Sullivan; R B Dewey; W G Ondo; G S Gronseth; W J Weiner Journal: Neurology Date: 2005-06-22 Impact factor: 9.910
Authors: J M Morales; F P Bermejo; J Benito-León; J Rivera-Navarro; R Trincado; R Gabriel S; S Vega Journal: Public Health Date: 2004-09 Impact factor: 2.427
Authors: J Benito-León; F Bermejo-Pareja; J M Morales-González; J Porta-Etessam; R Trincado; S Vega; E D Louis Journal: Neurology Date: 2004-03-09 Impact factor: 9.910
Authors: Hélio A G Teive; André R Troiano; Francisco M B Germiniani; Lineu C Werneck Journal: Parkinsonism Relat Disord Date: 2004-06 Impact factor: 4.891
Authors: Adebimpe W Kasumu; Charlotte Hougaard; Frederik Rode; Thomas A Jacobsen; Jean Marc Sabatier; Birgitte L Eriksen; Dorte Strøbæk; Xia Liang; Polina Egorova; Dasha Vorontsova; Palle Christophersen; Lars Christian B Rønn; Ilya Bezprozvanny Journal: Chem Biol Date: 2012-10-26
Authors: Yang Gao; Rónán O'Caoimh; Liam Healy; David M Kerins; Joseph Eustace; Gordon Guyatt; David Sammon; D William Molloy Journal: BMJ Open Date: 2013-07-25 Impact factor: 2.692
Authors: Andrew S Resnick; Michael S Okun; Teresita Malapira; Donald Smith; Fernando L Vale; Kelly Sullivan; Amber Miller; Israt Jahan; Theresa Zesiewicz Journal: Tremor Other Hyperkinet Mov (N Y) Date: 2012-04-06